222 related articles for article (PubMed ID: 37821935)
1. Hypoxia-induced SKA3 promoted cholangiocarcinoma progression and chemoresistance by enhancing fatty acid synthesis via the regulation of PAR-dependent HIF-1a deubiquitylation.
Chen Y; Xu X; Wang Y; Zhang Y; Zhou T; Jiang W; Wang Z; Chang J; Liu S; Chen R; Shan J; Wang J; Wang Y; Li C; Li X
J Exp Clin Cancer Res; 2023 Oct; 42(1):265. PubMed ID: 37821935
[TBL] [Abstract][Full Text] [Related]
2. Knockdown of tripartite motif 59 (TRIM59) inhibits proliferation in cholangiocarcinoma via the PI3K/AKT/mTOR signalling pathway.
Shen H; Zhang J; Zhang Y; Feng Q; Wang H; Li G; Jiang W; Li X
Gene; 2019 May; 698():50-60. PubMed ID: 30822475
[TBL] [Abstract][Full Text] [Related]
3. High expression of HIF-1α, BNIP3 and PI3KC3: hypoxia-induced autophagy predicts cholangiocarcinoma survival and metastasis.
Thongchot S; Yongvanit P; Loilome W; Seubwai W; Phunicom K; Tassaneeyakul W; Pairojkul C; Promkotra W; Techasen A; Namwat N
Asian Pac J Cancer Prev; 2014; 15(14):5873-8. PubMed ID: 25081716
[TBL] [Abstract][Full Text] [Related]
4. Potential role of HIF-1-responsive microRNA210/HIF3 axis on gemcitabine resistance in cholangiocarcinoma cells.
Silakit R; Kitirat Y; Thongchot S; Loilome W; Techasen A; Ungarreevittaya P; Khuntikeo N; Yongvanit P; Yang JH; Kim NH; Yook JI; Namwat N
PLoS One; 2018; 13(6):e0199827. PubMed ID: 29953500
[TBL] [Abstract][Full Text] [Related]
5. RPL35A promotes the progression of cholangiocarcinoma by mediating HSPA8 ubiquitination.
Zhang C; Wang Y; Wu G; Sun N; Bai H; Li X; Han S; Zhou H; Qi R; Zhang J
Biol Direct; 2024 Feb; 19(1):16. PubMed ID: 38395908
[TBL] [Abstract][Full Text] [Related]
6. Cyclophilin A enhances cell proliferation and tumor growth of liver fluke-associated cholangiocarcinoma.
Obchoei S; Weakley SM; Wongkham S; Wongkham C; Sawanyawisuth K; Yao Q; Chen C
Mol Cancer; 2011 Aug; 10():102. PubMed ID: 21871105
[TBL] [Abstract][Full Text] [Related]
7. Gene expression profiling of cholangiocarcinoma-derived fibroblast reveals alterations related to tumor progression and indicates periostin as a poor prognostic marker.
Utispan K; Thuwajit P; Abiko Y; Charngkaew K; Paupairoj A; Chau-in S; Thuwajit C
Mol Cancer; 2010 Jan; 9():13. PubMed ID: 20096135
[TBL] [Abstract][Full Text] [Related]
8. MicroRNA-144 suppresses cholangiocarcinoma cell proliferation and invasion through targeting platelet activating factor acetylhydrolase isoform 1b.
Yang R; Chen Y; Tang C; Li H; Wang B; Yan Q; Hu J; Zou S
BMC Cancer; 2014 Dec; 14():917. PubMed ID: 25479763
[TBL] [Abstract][Full Text] [Related]
9. YY1-induced DLEU1/miR-149-5p Promotes Malignant Biological Behavior of Cholangiocarcinoma through Upregulating YAP1/TEAD2/SOX2.
Li J; Jiang X; Xu Y; Kang P; Huang P; Meng N; Wang H; Zheng W; Wang H; Wang Z; Zhong X; Cui Y
Int J Biol Sci; 2022; 18(11):4301-4315. PubMed ID: 35864972
[TBL] [Abstract][Full Text] [Related]
10. Matrix metalloproteinase-2 inducing COL1A1 synthesis via integrin alpha Ⅴ promotes invasion and metastasis of cholangiocarcinoma cells.
Pan S; Hu Y; Gan L; Lai J; Zheng P; Zhang Y; Shuai L; Jiang Y; Chen M; Wang J; He Y
Ann Hepatol; 2024; 29(2):101279. PubMed ID: 38123132
[TBL] [Abstract][Full Text] [Related]
11. NUF2 Drives Cholangiocarcinoma Progression and Migration via Inhibiting Autophagic Degradation of TFR1.
Shan J; Jiang W; Chang J; Zhou T; Chen Y; Zhang Y; Wang J; Wang Y; Wang Y; Xu X; Liu S; Shi X; Fan S; Chen R; Li C; Li X
Int J Biol Sci; 2023; 19(5):1336-1351. PubMed ID: 37056930
[TBL] [Abstract][Full Text] [Related]
12. Micro-RNA-130a-3p Regulates Gemcitabine Resistance via PPARG in Cholangiocarcinoma.
Asukai K; Kawamoto K; Eguchi H; Konno M; Asai A; Iwagami Y; Yamada D; Asaoka T; Noda T; Wada H; Gotoh K; Nishida N; Satoh T; Doki Y; Mori M; Ishii H
Ann Surg Oncol; 2017 Aug; 24(8):2344-2352. PubMed ID: 28560603
[TBL] [Abstract][Full Text] [Related]
13. lnc-PKD2-2-3, identified by long non-coding RNA expression profiling, is associated with pejorative tumor features and poor prognosis, enhances cancer stemness and may serve as cancer stem-cell marker in cholangiocarcinoma.
Qiu G; Ma D; Li F; Sun D; Zeng Z
Int J Oncol; 2019 Jul; 55(1):45-58. PubMed ID: 31059014
[TBL] [Abstract][Full Text] [Related]
14. JUND/linc00976 promotes cholangiocarcinoma progression and metastasis, inhibits ferroptosis by regulating the miR-3202/GPX4 axis.
Lei S; Cao W; Zeng Z; Zhang Z; Jin B; Tian Q; Wu Y; Zhang T; Li D; Hu C; Lan J; Zhang J; Chen T
Cell Death Dis; 2022 Nov; 13(11):967. PubMed ID: 36400758
[TBL] [Abstract][Full Text] [Related]
15. Knockdown of PSMC2 contributes to suppression of cholangiocarcinoma development by regulating CDK1.
Duan X; Yang J; Jiang B; Duan W; Wei R; Zhang H; Mao X
Aging (Albany NY); 2021 Sep; 13(17):21325-21344. PubMed ID: 34499615
[TBL] [Abstract][Full Text] [Related]
16. Downregulated circular RNA hsa_circ_0001649 regulates proliferation, migration and invasion in cholangiocarcinoma cells.
Xu Y; Yao Y; Zhong X; Leng K; Qin W; Qu L; Cui Y; Jiang X
Biochem Biophys Res Commun; 2018 Feb; 496(2):455-461. PubMed ID: 29337065
[TBL] [Abstract][Full Text] [Related]
17. Long non-coding RNA MIR22HG inhibits cell proliferation and migration in cholangiocarcinoma by negatively regulating the Wnt/β-catenin signaling pathway.
Hu X; Tan Z; Yang Y; Yang P
J Gene Med; 2019 May; 21(5):e3085. PubMed ID: 30856284
[TBL] [Abstract][Full Text] [Related]
18. MCM2 promotes the proliferation, migration and invasion of cholangiocarcinoma cells by reducing the p53 signaling pathway.
Wang CL; Liu XY; Wang YH; Zhang Z; Wang ZD; Zhou GQ
Yi Chuan; 2022 Mar; 44(3):230-244. PubMed ID: 35307646
[TBL] [Abstract][Full Text] [Related]
19. BMI1 promotes cholangiocarcinoma progression and correlates with antitumor immunity in an exosome-dependent manner.
Liu Z; Hu C; Zheng L; Liu J; Li K; Li X; Wang Y; Mu W; Chen T; Shi A; Qiu B; Zhang X; Zhang Z; Xu Y
Cell Mol Life Sci; 2022 Aug; 79(9):469. PubMed ID: 35932322
[TBL] [Abstract][Full Text] [Related]
20. Circular RNA CDR1as Exerts Oncogenic Properties Partially through Regulating MicroRNA 641 in Cholangiocarcinoma.
Li D; Tang Z; Gao Z; Shen P; Liu Z; Dang X
Mol Cell Biol; 2020 Jul; 40(15):. PubMed ID: 32423991
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]